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Introduction
It has been known that the subfornical organ (SFO), one of circumventricular structures lacking normal
blood−brain barrier (１３), is an important site in the brain for dipsogenic responses (５,７,８, １０, １８, １９, ２２, ２３).
Ablation of the SFO (１８) or transection of SFO efferent projections (５) reduces or abolishes the drinking
response produced by an increase in the plasma level of angiotensin II (ANG II). Experimental findings in
several lines have revealed neural connections from the SFO to the hypothalamic nuclei thought to be
implicated in the mediation of drinking behavior, such as the median preoptic nucleus (MnPO) (５, １０‐１２, １７,
１９,２０,２３‐２５), the paraventricular nucleus (PVN) (７) and the lateral hypothalamic area (２２).
Previous studies have demonstrated that catecholamine depletions in the anteroventral third ventricle (AV３V)
region including the MnPO attenuate drinking and pressor responses and vasopressin release to many
dipsogenic and pressor stimuli (１,２,４), indicating that catecholaminergic inputs from the brain stem to the AV
３V region may play vital roles in the regulation of normal fluid balance and cardiovascular function.
Immunohistochemical tracing studies have shown that SFO neurons send angiotensinergic fibers to the MnPO
(１１, １２). It has been reported that destruction of the MnPO (１０) or inactivation of either angiotensinergic (１９,
２３) or noradrenergic (１９) systems in the MnPO diminishes the ANG II−induced drinking response elicited by
ANG II injected into the SFO. These findings provide the proposition that the NA system in the MnPO may
be involved in the elicitation of the drinking response to ANG II acting at the SFO.
The purpose of the present study was to explain more precisely the role of the noradrenergic system in
the MnPO in the dipsogenic response induced by ANG II activation of the SFO. We investigated the effects of
microinjection of ANG II into the SFO on the release of NA in the MnPO area and the effects of water
ingestion on the NA release using in vivo microdialysis techniques in freely moving rats. In an attempt to
determine whether an increase in arterial pressure produces changes in the NA release in the MnPO area, we
also examined the alteration in the release of NA in response to an elevation in arterial pressure elicited by
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individually in hanging wire cages for at least ２ weeks before testing. Water and food were available ad
libitum except where noted. Lights were on in the animal rooms for１２ h per day (light at ７：００−１９：００)， and
the temperature was maintained at２３−２５℃.
Surgery
The animals were anesthetized with sodium pentobarbital (６０ mg/kg, i.p.) and placed in a stereotaxic
frame. A microdialysis probe guide cannula (AG−１２, Eicom Co.) was lowered to coordinates which were １mm
dorsal to the MnPO since the probe assembly protrudes１mm below the ventral tip of the guide cannula when
inserted. A ２６−gauge stainless steel cannula was placed in the SFO, at a caudal angle of １５°. The guide and
injection cannulae were then fixed to the skull with acrylic dental cement and small stainless steel screws. The
２６−gauge cannula served as a guide for a ３３−gauge stainless steel injector cannula, which was inserted just
before injections. Each guide cannula was filled with an obturator of the same gauge as the injector cannula
when the animals were not being tested.
Drugs
For intracerebral injection, ANG II (Asp１−Ile５−ANG II) salt (Sigma) was dissolved in isotonic saline
vehicle and frozen in aliquots. Aliquots were thawed immediately before being used. For intravenous injection,
the α−agonist metaraminol (Aldrich) was dissolved in saline vehicle. The drug solution was prepared on the
day of the experiment.
Microdialysis
Microdialysis in the MnPO area and analysis of NA were performed by means of procedures described in
our previous studies (２０−２２). Briefly, the dialysis probe (AI−１−１２−１, Eicom Co.) whose tip had a １.０−mm−
long semipermeable membrane (in vivo recovery at ２ µl/min is almost ２５％) was inserted into the implanted
guide cannula. The probe was continuously perfused at a rate of ２ µl/min using a perfusion pump with a
solution (NaCl１４７mM, CaCl２ ２.３mM, KCl４mM). All dialysates were thus collected at２０ min intervals.
Intracranial injection
The third day after the implantation, the effects of microinjection of ANG II or vehicle into the SFO on
extracellular content of NA in the MnPO area were tested. The dialysis in the MnPO area was achieved ６−７ h
before the ANG II or vehicle injection into the SFO. The water bottle and the food box were removed１h
before the injection. Each rat was removed from its home cage, and the obturator was removed. The injector,
filled with injectate and connected to a １０ µl Hamilton gas chromatography syringe via approximately ８０ cm
of polyethylene tubing, was inserted into the implanted guide cannulae. The injectate within the tip of the
injector was separated from the tip of the cannula, and therefore from the rat, by a ２０ nl air bubble. The rat
was then placed in the metabolism cage. In the previous study, we have demonstrated that microinjection of
ANG II into the SFO in a dose of １０−６ M elicits a robust drinking response (１９, ２２). In this study, injections
of ANG II were thus administered in a dose of １０−６ M. Because it is crucial to minimize diffusion of
injectate in neuroanatomic localization experiments, all injections of the drug solution or vehicle were given in
a volume of ５０ nl. The injections were achieved at a rate of ５ nl/s. After the dialysis experiment, the animal
was placed in its home cage and water and food were available ad libitum before the start of the experiment
of the second day.
On the next day, the effects of water intake on the NA release in the MnPO area caused by the ANG II
injection in the same dose used in the first injection into the SFO were examined. Tap water was available ad
libitum immediately before the ANG II injection into the SFO. The latency to the onset of drinking was
recorded, and water intake was then monitored for １２０ min following the injection. To determine whether the
second injection of ANG II into the SFO causes similar alterations in the NA levels observed in the first
injection of the drug, the effects of the second injection of ANG II on the release of NA in the MnPO area
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were examined in a part of the animals (n＝６) under the condition without drinking.
Measurement of blood pressure and metaraminol adminstration
On the third day after the implantation，８ rats were anesthetized with urethane (１．４−１．５ g/kg b.w.t., i.p.).
A polyethylene cannula was inserted into the left femoral artery. The mean arterial pressure (M.A.P.) was
directly measured with a blood pressure transducer (P−５０, Gould Inc.) and a blood pressure meter (AP−６１１１G,
Nihon Koden), and recorded on a recorder (Ws−６８１G, Nihon Koden). The left femoral vein was catheterized
to inject the peripheral vasoconstrictor metaraminol. A tracheal cannula was inserted. The animal was then
paralyzed with tubocurarine (２ mg/kg b.w.t, i.p.) and artificially ventilated to prevent respiratory influence on
blood pressure. The rectal temperature was monitored and maintained at ３７±０．５ ℃. Metaraminol was
administered in a dose of５ µg. Microinjections of ANG II (１０−６ M，５０ nl) into the SFO were achieved at１００
min after the metaraminol administration.
Measurement of NA
The dialysates were analyzed for concentrations of NA, using HPLC (Eicom EP−１０) with electrochemical
detection (Eicom ECD−１００). A mobile phase consisting of ０．１M sodium acetate，０．１M citric acid，０．７５mM
sodium１−octanesulfonate, ０．３ mM EDTA and ２１％ methanol (pH ３．９) was used to elute the monoamine from
a reverse phase column (３．０ x １００ mm SC−３ODS column, Eicom Co.). The graphite working electrode was
set at ＋７５０mV versus a Ag/AgCl reference electrode and the flow rate was０．５ ml/min.
Histology
At the termination of each experiment, the animal was then sacrificed with an overdose of sodium
pentobarbital and perfused through the heart with isotonic saline to clear blood, which was followed by １０％
formalin for fixation. The brain was removed and stored in the formalin saline before being cut on a freezing
microtome at５０ µm in transverse sections. Sections were mounted on glass slides and stained with Neutral red
for microscope examination. The stereotaxic coordinates for the sites of dialysis probe and injection cannula
were determined according to the atlas of Paxinos and Watson (１４)．
Statistics
All values are expressed as mean ± S.E.M. Data were analyzed by means of one−way or two−way
repeated measures analysis of variance (ANOVAs) and subsequent Tukey’s protected t−test. A probability of
less than０．０５ was required for significance.
Results
Histological verification of the injection and dialysis sites
Histological analysis from the rat brains demonstrated that ２９ out of ３２ rats tested had the probe
placement in the MnPO (Fig. １D−F). The data from the remaining ３ rats having the probe placement outside
the MnPO were not included in the analysis. Of the ２９ animals having the probe placement in the MnPO, １６
and ６ received either the ANG II or vehicle injection into the SFO under the condition that accompanied
water intake on the second experimental day (Fig. １D) and the ANG II injection into the SFO under the
condition without water ingestion in either the first or second day (Fig. １E), respectively. The remaining ６ rats
were utilized for the examination of the effects of changes in arterial pressure on NA release in the MnPO
area (Fig.１F).
Of the１６animals that received the ANG II or vehicle injection，１５rats had correct SFO injector placement
(Fig. １A) such that ANG II administration produced a drinking response (more than ２．７ ml in ２０ min). The
remaining one rat with histology showing the tip of the injector through the ventral ependyma of the SFO
exhibited little drinking (０．２ ml in ２０ min) with the dose of the peptide used in this study and thus was not
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included in further analysis. In all cases in which the injector tip for ANG II administration was within ０．２
mm of the dorsal border of the SFO, the injection of the peptide would invariably result in a drinking
response (５．８±１．２ ml in ２０ min ;３９±１０ s ; n＝９). In all animals that received the second ANG II injection
into the SFO under the condition without water ingestion, the tip of the injection cannula was located within
or just above the SFO (Fig. １B). All animals tested for the effects of changes in arterial pressure on the NA
release had good SFO injector placements (Fig.１C).
Effects of water intake on the ANG II−induced NA release in the MnPO area
In the １５ rats having both good injector and probe placements, the effects of ANG II (n＝９) or saline
vehicle (n＝６) injections into the SFO on the release of NA in the MnPO area were examined under the
condition without water ingestion. The basal levels of NA in the MnPO area immediately before the ANG II
and saline vehicle injections into the SFO were １４．５±３．１ and １５．２±３．９ pg/４０µl dialysate, respectively. No
significant differences in the basal levels of NA were observed between the ANG II and vehicle treatment
groups. Injections of ANG II into the SFO significantly enhanced the NA release in the MnPO area compared
to the injection of saline (F(１,１３)＝３７．９６５, P＜０．００１, Fig.２A).
On the next day, the effects of water intake on the NA release in the MnPO area induced by ANG II
injected into the SFO were examined. Injections of ANG II into the SFO elicited a robust drinking response
within６０ min after the injection (P＜０，００１ for２０ min, P＜０．０１ for４０ min, P＜０．０５ for ６０ min ; n＝９; Fig. ２
B). The total water intake in １２０ min was ７．３±１．５ ml (ranging ２．９−１０．１ ml). The latency of drinking
response was ３７±８ s (ranging ７−９１ s). The saline injection into the SFO, on the other hand, did not cause
any significant water intake (total water volume in １２０ min, ０．３±０．１ ml ; n＝６; Fig. ２B). The baseline control
levels of NA immediately before the ANG II (１０．６±２．６ pg/４０µl dialysate ; F(１,１６)＝１２．５３０, P＜０．０５) or saline
(１１．０±２．８ pg/４０µl dialysate ; F(１,１０)＝１２．０７６, P＜０．０５) injection in the MnPO area were significantly lower
compared to those of the first experimental day. The ANG II injection into the SFO significantly increased the
NA release in the MnPO area compared to the saline injection (F(１,１３)＝２８．６３７, P＜０．００１, Fig.２A).
The amount of the increase in the NA release induced by ANG II injected into the SFO was much lower
Fig. １. A-C : The location of the cannula tips. A : Closed
and open circles on schematic transverse sections indicate
the loci of the cannulas that were utilized for microinjection
of ANG II and saline vehicle into the SFO, respectively. B :
Closed circles depict the loci of the cannulas in the rats
that received the ANG II injections under the condition
without drinking in both the first and second days. C :
Closed circles indicate the loci of the cannulas in the rats
that received the ANG II injection under urethane
anesthesia. D-F : Vertical bars on schematic illustrations
indicate the locations of the１-mm-long tip of the dialysis
probe in the MnPO. D : Closed and open bars depict the
locations of the probes in the rats that received the ANG II
and saline vehicle injections into the SFO, respectively. E :
Closed bars depict the probe placements in the rats that
received the ANG II injections under the condition without
drinking in both the first and second days. F : Closed bars
indicate the probe placements in the rats that received the
ANG II injection under urethane anesthesia. ac, anterior
commissure ; f, fornix ; MnPO, median preoptic nucleus ;
PT, paratenial thalamic nucleus ; SFO, subfornical organ ;
SHy, septo- hypothalamic nucleus ; sm, stria medullaris of
the thalamus ; TS, triangular septal nucleus ; vhc, ventral
hippocampal commissure ; ３V, third ventricle. Scale bar＝１
mm.
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in the condition that accompanied the water intake. To determine the statistical significance of this effect, a
two−way ANOVA was calculated for the data of Fig. ２A, with water treatment as the between−group factor
(two levels) and with time as the within−animal factor (eight levels). There were significant main effects of
treatment (F(１,１６)＝２７．４６９, P＜０．０１) and time (F(７,１１２)＝２１．７３６, P＜０．０１) and a significant interaction (F(７,
１１２)＝１９．９９５, P＜０．００１). In planned comparisons, the group without water intake differed from the group that
accompanied drinking at２０ min after the ANG II injection (P＜０．００１).
Effects of the repeat ANG II injection into the SFO on NA release in the MnPO area
To determine whether the repeat injection of the ANG II into the SFO influences on the release of NA in
the MnPO area, the effects of the second injection of the drug into the SFO on the NA release were
examined under the condition without drinking. The basal concentrations of NA immediately before the ANG
II injection into the SFO were significantly lower in the second day (１０．４±４．２ pg/４０µl dialysate; n＝６) than
in the first day (１４．３±３．９ pg/４０µl dialysate; n＝６) (F(１,１０)＝１０．７７２, P＜０．０５). In both the experimental days,
injections of ANG II into the SFO significantly enhanced the NA release in the MnPO area (Fig. ３). The
amount of the ANG II−induced increase in the NA release compared to the basal levels immediately before the
drug injection was similar on both days.
Fig. ２ Effects of water intake on the release of NA
caused by microinjection of ANG II into the SFO. A :
Changes in the release of NA in the MnPO area after
the injection of ANG II (filled and unfilled circles, n＝９)
and saline vehicle (filled and unfilled triangles, n＝６)
into the SFO. Values are expressed as percentage of
the sample taken immediately before the injection.
Results in this and subsequent figures except for Fig.４
A are shown as mean ± S.E.M. The filled circles and
triangles indicate the alterations in the NA release
under the condition without drinking. The unfilled circles
and triangles indicate the changes in the NA release
under the condition that accompanied water intake. *P
＜０．０１, **P＜０．００１compared with the basal control level
(０min). †P＜０．００１compared with those of the ANG II
injection under the condition that accompanied water
intake (filled circle) at ２０min. B : The water intake (in
each ２０min) in response to the ANG II injection (closed
histogram bars, n＝８) or the vehicle injection (open
histogram bars, n＝６) into the SFO. *P＜０．０５, **P＜０．０１,
***P＜０．００１ compared with those of the saline injection.
Fig. ３. Effects of repeat injection of ANG II on the
release of NA in the MnPO area under the condition
without drinking. Changes in the NA release are
expressed as percentage of the sample taken
immediately before the microinjection (n＝６). Circles
and open circles indicate the alterations in the NA
release in response to the first and second injection
of ANG II into the SFO, respectively. *P＜０．０５, **P＜
０．００１ compared with the basal control level (０ min).
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NA release in the MnPO area to an elevation in blood pressure
The basal concentrations of NA in the MnPO area were１３．８±２．９ pg/４０µl dialysate (n＝７) under urethane
anesthesia. Intravenous infusions of metaraminol significantly decreased the NA release in the MnPO area that
accompanied a １８−４１ mmHg (２３±５ mmHg) elevation in M.A.P. (F(１,１０)＝１４．９９０, P＜０．０１) (Fig. ４). Injections
of ANG II into the SFO, on the other hand, significantly increased the release of NA in the MnPO area (F(１,
１０)＝４３．９５７, P＜０．００１) that accompanied a１８−３８ mmHg (２２±５ mmHg) increase in M.A.P. (Fig.４).
Discussion
The present data show that ANG II injected into the SFO enhances the release of NA in the MnPO area,
and are consistent with the previous report (２０). It has been suggested that ANG II acts as a neuromodulator
in the central nervous system because of its interactions with neurotransmitters, especially the catecholamines
(４, １５). Neuroanatomical studies have revealed that neurons in the SFO send angiotensinergic fibers to the
MnPO (１１, １２) and that stimulation of the SFO enhances the activity of MnPO neurons through ANG II
receptors (２４, ２５). It has been shown that ANGII can increase the release of NA in the hypothalamus, perhaps
via a presynaptic mechanism (６, ２１). Thus, it is suggested the hypothesis that, in the MnPO area, ANG II
released from angiotensinergic nerve terminals following activation of the SFO acts onto NA terminals, as a
presynaptic mechanism, which result in increased NA release. However, there is no previous literature that the
angiotensinergic fibers arising from the SFO terminate on NA terminals in the MnPO. Anatomical studies have
revealed that the MnPO is richly innervated by noradrenergic nerve terminals derived from ３ cell groups, the
locus coeruleus, the A２ cell group in the dorsal vagus complex, and the A１cell group in the ventrolateral
medulla (１６, １７). On the other hand, the existence of efferent projections from the SFO which are able to
activate these noradrenergic cells in the brain stem is not known. It has been shown that the SFO is also
innervated by noradrenergic projections from the A１and A２ cell groups (３, ９). If a single NA neuron projects
simultaneously to the MnPO and the SFO, it would be possible that stimulation of the SFO per se causes NA
release in the MnPO area via an axon reflex. The precise mechanisms underlying the increased NA release
elicited by the ANG II injection into the SFO remains to be explained.
Fig. ４. Effects of increases in blood pressure
following intravenous administration of metaraminol
and microinjection of ANG II into the SFO on the
release of NA in the MnPO area under urethane
anesthesia. Values are expressed as percentage of
the sample taken immediately before the
intravenous injection of metaraminol. Arrows
indicate the time of injection of the drugs. A : An
example of the change in the NA release (upper)
and mean arterial pressure (M.A.P., lower) to the
intravenous injection of metaraminol and injection
of ANG II into the SFO. B : Results in the７rats
tested are summarized. *P＜０．０１, **P＜０．００１
compared with the basal control level (０ min).
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In the present study, the elevation in the NA release in the MnPO area elicited by ANG II injected into
the SFO was significantly reduced by water intake. The results provide the first demonstration that water
ingestion attenuates the release of NA in the MnPO area induced by ANG II activation of the SFO, and
suggest that the noradrenergic system in the MnPO plays an important role in the mediation of dipsogenic
response induced by activation of SFO neurons in response to an increase in the circulating level of ANG II.
It has been demonstrated that NA depletions in the AV３V region lead to attenuated drinking (１, ２, ８).
Reduction of systemic fluid volume has been shown to enhance NA turnover in the MnPO area (２１, ２６). In
addition, a recent report has indicated that inactivation of either angiotensinergic or α−adrenergic systems in the
MnPO following local administration of the antagonists diminishes the water intake induced by ANG II
injected into the SFO (１９). These observations and our data suggest the proposition that the release of NA in
the MnPO may be an excitatory step along the ANG II−eliciting thirst pathway, and imply that signals from
peripheral organs such as the stomach in response to water intake may decrease neural inputs of noradrenergic
projections to the MnPO and/or the activity of noradrenergic system in the MnPO.
Previous observations have suggested that activation of SFO neurons produces an increase in blood
pressure through their efferent fibers to the MnPO (８, ２４). Although either ANG II injected into the SFO or
metaraminol administered intravenously elicited an elevation in arterial pressure, the opposite effects of ANG II
and metaraminol on the release of NA were found in this study, suggesting the possibility that an elevation in
arterial pressure may be not attribute to the increased NA release caused by ANG injected into the SFO.
However, it has been demonstrated that the noradrenergic system in the MnPO is implicated in the regulation
of the blood pressure response to ANG II (１, ２). Additionally, it remains to verify the possibility that
metaraminol may penetrate the blood−brain barrier or influence on SFO neurons via fenestrated capillaries.
Thus, we cannot answer the question of whether an increase in arterial pressure may be involved in the
enhanced NA release in the MnPO area.
In conclusion, the present data show that ANG II injected into the SFO enhances the release of NA in
the MnPO and the NA release is reduced by water ingestion, suggesting that the noradrenergic system in the
MnPO may participate in the modulation of the dipsogenic response induced by ANG II acting at the SFO.
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Abstract
The present study was carried out to investigate the role of noradrenergic systems in the median preoptic
nucleus (MnPO) in the drinking response caused by microinjection of angiotensin II (ANG II) into the
subfornical organ (SFO) in the awake rat. Extracellular levels of noradrenaline (NA) in the region of the
MnPO were monitored with in vivo microdialysis methods. Injections of ANG II (１０−６ M，５０ nl) into the SFO
significantly increased NA release in the MnPO area. The increase in the NA release induced by the ANG II
injection was significantly reduced by water ingestion. In urethane−anesthetized rats, injections of ANG II into
the SFO produced an elevation in mean arterial pressure (M.A.P.). Intravenous infusions of metaraminol (５ µg),
on the other hand, slightly suppressed the release of NA in the MnPO area that accompanied an elevation in
M.A.P. These results suggest that the noradrenergic system in the MnPO may be involved in the dipsogenic
response induced by ANG II acting at the SFO.
Water Intake Reduces the Noradrenaline Release in the Median
Preoptic Nucleus Area Caused by Angiotensin II Injected
into the Subfornical Oragn in the Rat
Junichi TANAKA＊, Hiroko MIYAKUBO＊＊
Ayako KAWAKAMI＊ and Yasushi HAYASHI＊＊＊
＊＊＊Department of Curriculum, Teaching and Memory, Naruto University of Education
＊＊＊Joint Graduate School in the Science of School Education, Hyogo University of School Education
＊＊＊Department of Human Nutrition, Faculty of Human Life Sciences, Notre Dame Seishin University
―２９６―
